Skip to main navigation
Aligos Therapeutics Logo

    Investor Relations

  • Overview
  • Stock
    Stock Quote & Chart
  • News & Events
    News Releases Investor Calendar Presentations
  • Financials
    SEC Filings
  • Governance
    Governance Highlights Committee Composition
  • Resources
    Investor FAQs Email Alerts Contact IR

News Releases

Jan 07, 2021
Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that CEO Lawrence Blatt, Ph.D.,

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • Investor FAQs
  • © Aligos Therapeutics 2021